TrialLeukemia2015

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia.

A K Burnett et al.PubMed ↗Publisher ↗

No numbers read from the abstract.